GB202011149D0 - Use of cannabidiol in the treatment of seizures associated with stroke or brain haemorrhage - Google Patents
Use of cannabidiol in the treatment of seizures associated with stroke or brain haemorrhageInfo
- Publication number
- GB202011149D0 GB202011149D0 GBGB2011149.8A GB202011149A GB202011149D0 GB 202011149 D0 GB202011149 D0 GB 202011149D0 GB 202011149 A GB202011149 A GB 202011149A GB 202011149 D0 GB202011149 D0 GB 202011149D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cannabidiol
- stroke
- treatment
- seizures associated
- brain haemorrhage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2011149.8A GB2597302A (en) | 2020-07-20 | 2020-07-20 | Use of cannabidiol in the treatment of seizures associated with stroke or brain haemorrhage |
| PCT/EP2021/069898 WO2022017957A1 (en) | 2020-07-20 | 2021-07-15 | Use of cannabidiol in the treatment of seizures associated with stroke or brain haemorrhage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2011149.8A GB2597302A (en) | 2020-07-20 | 2020-07-20 | Use of cannabidiol in the treatment of seizures associated with stroke or brain haemorrhage |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB202011149D0 true GB202011149D0 (en) | 2020-09-02 |
| GB2597302A GB2597302A (en) | 2022-01-26 |
Family
ID=72339042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2011149.8A Pending GB2597302A (en) | 2020-07-20 | 2020-07-20 | Use of cannabidiol in the treatment of seizures associated with stroke or brain haemorrhage |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB2597302A (en) |
| WO (1) | WO2022017957A1 (en) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999053917A1 (en) * | 1998-04-21 | 1999-10-28 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Cannabinoids as antioxidants and neuroprotectants |
| GB2530001B (en) * | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
| GB2531282A (en) * | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2531280A (en) * | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
| GB2531278A (en) * | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
| GB2539472A (en) * | 2015-06-17 | 2016-12-21 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB201806953D0 (en) * | 2018-04-27 | 2018-06-13 | Gw Res Ltd | Cannabidiol Preparations |
-
2020
- 2020-07-20 GB GB2011149.8A patent/GB2597302A/en active Pending
-
2021
- 2021-07-15 WO PCT/EP2021/069898 patent/WO2022017957A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| GB2597302A (en) | 2022-01-26 |
| WO2022017957A1 (en) | 2022-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276217A (en) | Use of cannabinoids in the treatment of epilepsy | |
| IL283372A (en) | Use of cannabinoids in the treatment of epilepsy | |
| GB2568809B (en) | Use of cannabinoids in the treatment of epilepsy | |
| IL285662A (en) | Use of cannabinoids in the treatment of epilepsy | |
| GB2568471B (en) | Use of cannabinoids in the treatment of epilepsy | |
| IL274769A (en) | Use of cannabinoids in the treatment of epilepsy | |
| IL284758A (en) | Use of cannabinoids in the treatment of comorbidities associated with epilepsy | |
| GB201907283D0 (en) | Use of cannabidiol in the treatment of epileptic spams | |
| JOP20200035A1 (en) | Amino acid compositions for the treatment of neuronal injury | |
| GB202014723D0 (en) | Use of cannabinoids in the treatment of epilepsy | |
| GB202019301D0 (en) | Use of cannabidiol in the treatment of seizures associated with epilepsy syndromes | |
| GB2590793B (en) | Cannabidiol-C1 for use as a medicament and in the treatment of epilepsy | |
| GB201912244D0 (en) | Use of cannabinoids in the treatment of dyskinesia associated with parkinson's disease | |
| WO2019173795A3 (en) | Reduction of er-mam-localized app-c99 and methods of treating alzheimer's disease | |
| IL287704A (en) | Use of cannabidiol in the treatment of tuberous sclerosis complex | |
| GB201915522D0 (en) | Use of cannabidiol preparations in the treatment of absence epilepsy | |
| IL275349A (en) | Use of hm4di in the treatment of seizure disorders | |
| GB202011123D0 (en) | Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to brain injury | |
| GB201915519D0 (en) | Use of cannabidiol preparations in the treatment of temporal lobe epilepsy | |
| GB202011149D0 (en) | Use of cannabidiol in the treatment of seizures associated with stroke or brain haemorrhage | |
| GB202102010D0 (en) | Use of cannabidivarin in the treatment of seizures associated with canine epilepsy | |
| GB202011154D0 (en) | Use of cannabidiol in the treatment of seizures associated with encephaltis | |
| GB202011142D0 (en) | Use of cannabidiol in the treatment of seizures associated with brain damage | |
| GB202011126D0 (en) | Use of cannabidiol in the treatment of sezures associated with mutifocal epilepsy | |
| EP3703820A4 (en) | Use of mir101 or mir128 in the treatment of seizure disorders |